Drug intelligence / Profile preview

热痹膏

Development stage: Preclinical
Administration: Topical

Overview

**热痹膏** is a topical traditional Chinese medicine preparation reported in a clinical-observation study as an external adjunct to orally administered Western medicines for rheumatoid arthritis with a traditional Chinese medicine wet-heat obstruction pattern. Publicly available information confirms topical use in this clinical context, but does not reliably identify its complete ingredient composition, manufacturer, developer, standardized pharmacologic targets, or a defined molecular mechanism.

Other names: Rebi Gao

Beyond the preview

Go deeper on 热痹膏.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 热痹膏.

Explore the full profile